multipl
sclerosi
ms
chronic
inflammatori
diseas
cn
broad
rang
therapeut
effect
reduc
incid
focal
white
matter
inflamm
plaqu
format
patient
relapseremit
form
ms
challeng
within
field
develop
therapi
allow
axon
protect
remyelin
last
decad
grow
interest
focus
util
neural
precursor
cell
npc
promot
remyelin
understand
npc
function
chronic
demyelin
environ
sever
excel
preclin
mous
model
develop
one
well
accept
model
infect
suscept
mice
neurotrop
variant
mous
hepat
viru
mhv
undergo
chronic
demyelin
exhibit
clinic
histopatholog
similar
ms
patient
combin
possibl
environment
agent
viru
could
trigger
ms
mhv
model
demyelin
present
relev
mous
model
assess
therapeut
potenti
npc
transplant
environ
inflammatorymedi
demyelin
establish
neural
precursor
cell
npc
repres
heterogen
stemlik
cell
capabl
selfrenew
multipot
differenti
potenti
within
develop
fulli
matur
cn
year
ago
pioneer
research
demonstr
npc
could
isol
cultur
ex
vivo
mitot
activ
region
within
embryon
rat
mous
differenti
neuron
glia
sinc
stringent
cultur
protocol
develop
enabl
research
gener
highpur
npc
safe
variou
mammalian
sourc
includ
embryon
adult
tissu
uncommit
natur
npc
make
promis
therapeut
candid
human
demyelin
diseas
multipl
sclerosi
ms
npc
potenti
replac
damag
nonfunct
cell
within
cn
promot
repair
recoveri
also
known
secret
immunomodulatori
neurotroph
factor
expand
therapeut
potenti
cell
order
assess
function
role
engraft
npc
import
fulli
understand
broad
rang
inflammatori
nich
may
support
npc
surviv
function
mous
hepat
viru
mhv
model
demyelin
relev
ms
model
differ
autoimmunemedi
demyelin
includ
experiment
autoimmun
encephalomyel
eae
well
glial
toxin
model
exampl
cuprizon
lysolecithin
ethidium
bromid
mice
infect
neurotroph
variant
mhv
mice
undergo
chronic
demyelin
promot
effector
activ
virusspecif
nonspecif
cell
given
possibl
viral
infect
initi
demyelin
human
well
fact
numer
neurotroph
virus
exist
capabl
persist
within
cn
import
evalu
therapeut
potenti
engraft
npc
presenc
persist
viral
infect
correl
chronic
neuroinflamm
demyelin
ms
complex
diseas
cn
character
heterogen
patholog
compos
inflammatori
neurodegen
compon
although
identif
etiolog
trigger
ms
remain
elus
diseas
induct
thought
result
sever
featur
includ
genet
predisposit
environment
factor
exampl
microbi
infect
common
histopatholog
featur
earli
stage
diseas
includ
intermitt
episod
acut
inflamm
within
patch
white
matter
result
demyelin
myelin
critic
maintain
effici
axon
conduct
oligodendrocyt
myelin
produc
maintain
axon
health
within
cn
damag
destroy
ms
patient
focal
attack
earli
diseas
gener
episod
vari
h
sever
week
length
usual
follow
near
complet
recoveri
clinic
symptom
diseas
cours
collect
refer
relapseremit
ms
rrm
spontan
remiss
associ
wane
inflamm
partial
restor
axon
conduct
due
remyelin
endogen
oligodendrocyt
precursor
cell
opc
found
univers
dispers
within
human
cn
found
high
densiti
within
subacut
lesion
earli
stage
ms
within
subacut
demyelin
lesion
perivascular
infiltr
compos
activ
cell
well
macrophag
thought
act
concert
reactiv
microglia
releas
milieu
proinflammatori
factor
lead
oligodendrocyt
dysregul
addit
clonal
expand
class
restrict
cell
found
close
proxim
demyelin
axon
potenti
target
myelin
epitop
remyelin
follow
opc
matur
lead
format
shadow
plaqu
patch
remyelin
white
matter
compos
disproport
thin
myelin
sheath
surround
axon
although
rrm
last
throughout
individu
lifespan
approxim
patient
rrm
develop
progress
diseas
within
two
decad
follow
diagnosi
wherea
individu
diagnos
ms
classifi
progress
patient
gener
progress
ms
latest
stage
diseas
character
gradual
worsen
symptom
without
remiss
sever
neurolog
impair
dramat
reduc
qualiti
life
individu
mainli
attribut
expand
cortic
lesion
impact
motor
function
patholog
widespread
axon
degener
grey
matter
neuropathi
without
signific
presenc
adapt
arm
immun
contribut
immunopatholog
rather
diffus
white
gray
matter
inflamm
report
correl
part
global
microgli
activ
well
presenc
cell
b
cell
myelinladen
macrophag
restrict
border
preexist
lesion
furthermor
overal
failur
opc
effici
remyelin
damag
white
gray
matter
area
dramat
reduc
possibl
recoveri
use
preclin
mous
model
demyelin
studi
ms
research
identifi
antigen
cellular
compon
diseas
believ
contribut
demyelin
led
develop
therapeut
advanc
gener
favor
longterm
prognos
patient
mani
us
fdaapprov
therapi
show
potent
immunosuppress
properti
act
limit
leukocyt
infiltr
brain
therebi
reduc
relaps
event
howev
patient
progress
diseas
therapeut
repertoir
treatment
decis
make
confound
partial
reflect
reduc
efficaci
mani
drug
whose
mode
action
inhibit
leukocyt
infiltr
cn
rather
target
cell
implic
acceler
progress
diseas
reactiv
astrocyt
microglia
degener
neuron
addit
intact
bloodbrain
barrier
bbb
progress
ms
may
compartment
inflammatori
leukocyt
within
cn
make
mani
drug
inact
due
inabl
penetr
reconstitut
bbb
importantli
patient
progress
ms
fact
treatment
option
act
halt
even
slow
demyelin
axon
loss
one
therapeut
option
treat
progress
ms
would
replenish
rejuven
pool
endogen
opc
show
limit
remyelin
potenti
later
stage
diseas
among
plethora
experiment
approach
attempt
promot
remyelin
repair
cellular
replac
therapi
use
npc
emerg
clinic
relev
area
research
recent
success
demonstr
bone
marrowderiv
mesenchym
neural
precursor
cell
deriv
mous
human
show
therapeut
potenti
promot
recoveri
preclin
mous
ms
model
result
fdaapprov
phase
safetyfeas
clinic
trial
progress
ms
patient
use
autolog
bone
marrowderiv
mesenchym
neural
precursor
cell
moreov
transplant
human
fetalderiv
npc
frontal
lobe
children
pelizaeusmerbach
diseas
rare
dysmyelin
disord
children
reveal
measur
gain
motor
andor
cognit
associ
remyelin
therefor
cn
deliveri
hnpc
potenti
viabl
import
approach
treat
human
demyelin
diseas
ms
intracrani
inocul
mice
neurotroph
jhm
strain
mous
hepat
viru
jhmv
result
dissemin
viral
particl
throughout
ventricular
system
target
ependym
cell
line
ventricl
viru
penetr
parenchyma
brain
spinal
cord
oligodendrocyt
astrocyt
microglia
suscept
infect
neuron
spar
robust
innat
hostdefens
respons
jhm
infect
soon
follow
character
secret
proinflammatori
factor
type
interferon
essenti
role
protect
host
jhm
infect
mice
defici
receptor
show
elev
viral
load
within
cn
higher
mortal
exogen
treatment
mice
either
type
interferon
limit
dissemin
viru
furthermor
innat
cellular
compon
consist
neutrophil
macrophag
natur
killer
nk
cell
respond
jhmv
infect
rapidli
migrat
cn
assist
permeabil
bbb
bbb
permeabil
promot
infiltr
sensit
jhmvspecif
cell
exert
potent
antivir
effector
mechan
virusspecif
cell
function
support
cell
cell
promot
tcell
expans
peripheri
promot
surviv
cytotox
within
cn
addit
cell
control
viral
spread
releas
serv
dual
role
inhibit
viral
replic
within
oligodendrocyt
also
induc
upregul
mhc
class
ii
express
microglia
deplet
cell
alter
cellmedi
control
viral
replic
within
cn
mainli
result
reduc
express
elev
tcell
apoptosi
virusspecif
cell
primari
cytolyt
effector
cell
within
cn
jhm
infect
peak
accumul
coincid
viral
clearanc
glia
ex
vivo
analysi
immunodomin
jhmvspecif
cell
jhmvinfect
mice
reveal
elev
express
cytolyt
compon
granzym
b
perforin
vivo
upregul
mhci
promot
perforinmedi
cytolysi
jhmvinfect
astrocyt
microglia
fasfasl
tnfr
signal
infect
cell
appear
contribut
viral
clearanc
oligodendrocyt
initi
reservoir
viral
replic
howev
appear
resist
perforinmedi
cytolysi
cell
rather
control
viral
replic
receptor
signal
find
support
stohlman
colleagu
demonstr
express
domin
neg
version
ifngr
oligodendrocyt
result
increas
tropism
viral
load
within
oligodendroglia
throughout
brain
spinal
cord
mice
surviv
acut
jhmv
infect
progress
immunemedi
chronic
demyelin
phase
diseas
clinic
symptom
manifest
ataxia
partial
complet
hind
limb
paralysi
begin
week
follow
infect
peak
week
pi
histolog
cross
section
spinal
cord
mice
undergo
jhmvinduc
demyelin
demonstr
oligodendrocyt
dysfunct
loss
myelin
integr
within
white
matter
tract
close
associ
presenc
inflammatori
leukocyt
present
viral
antigen
via
mhci
mhcii
rather
widespread
apoptosi
andor
necrosi
matur
oligodendrocyt
moreov
pauciti
infecti
viral
particl
within
cn
chronic
diseas
suggest
product
infect
new
glial
cell
amplifi
demyelin
like
viral
rna
quasispeci
present
within
cn
persist
infect
mice
promot
chronic
inflamm
demyelin
effect
way
visual
quantifi
demyelin
macroscop
scale
via
luxol
fast
blue
lfb
stain
lfb
contain
copper
phthalocyanin
dye
readili
bind
lipoprotein
found
myelin
sheath
result
blue
stain
myelinrich
region
lack
stain
within
demyelin
lesion
lfb
analysi
spinal
cord
section
persist
jhmvinfect
reveal
new
lesion
format
within
anterior
funiculu
spinal
cord
earli
day
pi
sever
neuroinflamm
increas
new
lesion
often
observ
within
later
funiculu
posterior
funiculu
figur
addit
axonopathi
within
white
matter
tract
spinal
cord
present
observ
use
bielschowski
silver
impregn
stain
initi
observ
suggest
occur
concomitantli
demyelin
wherea
axon
degener
argu
preced
oligodendrocyt
dysregul
ms
sever
studi
identifi
cell
macrophag
main
cellular
compon
induc
demyelin
chronic
jhmv
infect
mice
rather
viralinduc
lysi
oligodendrocyt
stem
studi
show
jhmv
infect
immunodefici
mice
lack
function
tand
blymphocyt
result
extens
viral
replic
within
oligodendrocyt
limit
demyelin
moreov
adopt
transfer
jhmvsensit
splenocyt
wildtyp
mice
jhmvinfect
result
demyelin
adopt
transfer
enrich
cell
obtain
jhmvsensit
mice
jhmvinfect
mice
result
reduc
sever
demyelin
compar
recipi
cell
implic
express
infiltr
cell
import
contributor
oligodendrocyt
dysregul
studi
util
mice
demonstr
import
tcell
subset
contribut
demyelin
follow
jhmv
infect
regard
impact
oligodendrocyt
health
numer
report
demonstr
enhanc
sensit
opc
apoptosi
compar
matur
oligodendrocyt
suggest
induc
cell
death
oligodendrocytelineag
cell
depend
matur
state
support
find
demyelin
observ
within
jhmvinfect
mice
whose
select
ablat
receptor
matur
oligodendrocyt
could
partial
explain
secret
cell
promot
migrat
accumul
activ
macrophagesmicroglia
within
white
matter
tract
jhmvinfect
mice
inde
ultrastructur
immunofluoresc
analysi
jhmvinduc
demyelin
lesion
featur
macrophagesmicroglia
engulf
myelin
near
demyelin
axon
howev
discrimin
cell
type
immunophenotyp
light
microscopi
remain
challeng
determin
exact
role
play
contribut
patholog
chronic
neurolog
diseas
recent
ransohoff
colleagu
use
electron
microscopi
show
pathogen
role
macrophag
compar
microglia
eae
model
ms
epitop
spread
appear
autoreact
cell
host
neuroantigen
thought
contribut
demyelin
chronic
jhmv
infect
altogeth
find
suggest
demyelin
multifacet
numer
factor
could
contribut
patholog
numer
experiment
model
cn
injuri
demonstr
endogen
opc
respond
ongo
demyelin
prolifer
matur
restor
deplet
pool
matur
oligodendrocyt
activ
particip
cn
remyelin
follow
jhmv
infect
pdgfrposit
opc
found
within
spinal
cord
increas
sixfold
day
pi
suggest
opc
becom
mitot
activ
follow
onset
demyelin
addit
rebound
total
frequenc
matur
oligodendrocyt
preinfect
level
week
pi
also
observ
presum
due
matur
expand
opc
popul
nevertheless
opc
differenti
lead
substanti
clinic
recoveri
full
remyelin
within
persist
infect
mice
expos
axon
still
detect
month
later
follow
infect
figur
sever
studi
identifi
sever
cytokin
chemokin
growth
factor
impact
opc
prolifer
matur
vivo
exampl
signal
chemokin
receptor
shown
enhanc
opc
prolifer
aid
direct
migrat
opc
within
develop
mous
spinal
cord
inhibit
result
reduc
prolifer
increas
matur
autoimmun
model
demyelin
use
variant
mhv
armstrong
colleagu
demonstr
pdgf
regul
opc
biolog
stimul
prolifer
limit
matur
activ
notch
signal
pathway
within
context
jhmvinduc
neurolog
diseas
signal
axi
may
also
play
crucial
role
aid
opc
matur
inde
block
abil
bind
use
small
molecul
lead
increas
pdgfraposit
opc
decreas
matur
oligodendrocyt
within
spinal
cord
suggest
signal
promot
opc
differenti
result
support
extend
klein
colleagu
show
activ
scaveng
receptor
well
result
opc
matur
cuprizoneinduc
demyelin
better
understand
potenti
therapeut
role
npc
intraspin
engraft
demyelin
environ
chose
day
postjhmv
infect
anim
surviv
acut
stage
diseas
persist
infect
viru
clinic
diseas
congruent
neuroinflamm
demyelin
studi
migratori
function
role
npc
without
possibl
reject
earli
studi
util
syngen
transplant
protocol
wherebi
haplotypematch
mous
striatal
npc
postnat
day
mice
transplant
intraspin
region
recipi
mice
undergo
jhmvinduc
demyelin
initi
result
demonstr
transplant
npc
readili
migrat
mm
rostral
caudal
transplant
site
identifi
coloc
oligodendrocyt
marker
prolifer
marker
brdu
quantif
remyelin
axon
result
axon
remyelin
compar
nontranspl
control
suggest
npc
surviv
within
inflammatori
nich
function
incorpor
throughout
demyelin
white
matter
tract
follow
differenti
matur
oligodendrocyt
addit
studi
carbaj
et
al
demonstr
transplant
gfpnpc
shown
select
colon
demyelin
white
matter
region
within
ventral
later
funiculu
region
spinal
cord
posit
migrat
npc
mediat
part
respond
cxc
chemokin
ligand
via
express
receptor
express
upon
engraft
npc
determin
whether
reduct
clinic
diseas
due
cell
modifi
inflammatori
microenviron
reduc
overal
inflamm
increas
recoveri
mice
receiv
mous
npc
sacrif
day
posttranspl
leukocyt
infiltr
assess
flow
cytometri
npc
transplant
alter
accumul
cell
macrophag
within
cn
proinflammatori
chemokin
cytokin
gene
express
suggest
enhanc
remyelin
recoveri
follow
transplant
result
npc
bystand
effect
attenu
inflammatori
respons
import
question
relat
npc
transplant
whether
engraft
cell
capabl
directli
remyelin
axon
creat
nurs
effect
secret
trophic
factor
capabl
promot
matur
endogen
opc
myelin
oligodendrocyt
evalu
contribut
transcript
factor
npc
differenti
remyelin
defin
condit
npc
preferenti
differenti
oligodendroglia
wherea
npc
isol
mice
exhibit
enhanc
differenti
astrocyt
transplant
npc
jhmvinfect
mice
result
similar
cell
surviv
prolifer
select
migrat
area
demyelin
howev
recipi
wildtyp
npc
exhibit
extens
remyelin
compar
mice
receiv
vivo
character
npc
reveal
npc
preferenti
differenti
opc
form
process
express
myelin
basic
protein
encircl
axon
contrast
major
transplant
differenti
gfapposit
cell
consist
astrocyt
lineag
find
reveal
function
requir
remyelin
potenti
npc
transplant
specif
andor
mainten
oligodendrogli
ident
addit
recent
employ
twophoton
microscopi
assess
intercellular
interact
transplant
npc
ex
vivo
within
model
jhmvinfect
mice
express
yellow
fluoresc
protein
yfp
mediumtolarg
calib
axon
within
spinal
cord
receiv
svzderiv
npc
express
gfp
follow
differenti
oligodendrocyt
plpgfp
sever
import
observ
deriv
studi
includ
find
jhmvinfect
mice
display
extens
axon
damag
earlier
expect
jhmvinduc
diseas
suggest
appear
axonopathi
preced
robust
immunemedi
demyelin
argu
axon
damag
may
import
contribut
white
matter
damag
myelin
loss
whether
viral
infect
neuron
andor
transport
viral
protein
along
axon
import
process
current
well
defin
addit
twophoton
imag
clearli
show
engraft
npc
interact
damag
axon
result
remyelin
improv
axon
integr
determin
yfp
express
figur
addit
step
better
understand
therapeut
potenti
engraft
npc
promot
clinic
histolog
recoveri
transplant
mhcmismatch
mous
npc
jhmvinfect
mice
establish
demyelin
determin
whether
allogen
npc
recogn
foreign
reject
via
immunolog
mechan
clinic
relev
transplant
human
npc
patient
pelizaeusmerbach
diseas
requir
administr
immunosuppress
drug
limit
potenti
reject
similarli
transplant
human
embryon
stem
cell
hesc
opc
individu
spinal
cord
injuri
also
perform
conjunct
administr
immunosuppress
drug
studi
palmer
colleagu
shown
import
role
compon
innat
immun
respons
includ
nk
cell
recogn
reject
mhcmismatch
npc
follow
transplant
brain
mice
similarli
demonstr
engraft
allogen
npc
spinal
cord
jhmvinfect
mice
result
reject
mediat
part
tlymphocyt
well
nk
cell
npc
respond
well
viral
infect
term
express
mhc
class
ii
well
retino
acid
earli
precursor
allow
tlymphocyt
nk
recognit
respect
collect
find
highlight
npc
recogn
cellular
compon
innat
adapt
immun
respons
indic
administr
immunosuppress
drug
must
consid
order
promot
longterm
surviv
function
although
syngen
allogen
transplant
mous
npc
gener
valuabl
insight
mechan
npc
function
inflammatori
cn
environ
anoth
import
research
object
assess
therapeut
efficaci
engraft
human
npc
opcderiv
cell
jhmvinfect
mice
previous
transplant
highpur
predifferenti
human
opc
mice
undergo
jhmvinduc
demyelin
result
limit
clinic
recoveri
engraft
cell
reject
within
week
posttransplant
even
presenc
immunosuppress
drug
target
activ
tlymphocyt
histolog
result
slight
increas
remyelin
near
transplant
site
compar
hbss
transplant
mice
contrast
earlier
studi
use
hescderiv
opc
model
spinal
cord
injuri
rat
enhanc
remyelin
improv
motor
function
observ
follow
transplant
altern
human
npc
previous
shown
exert
neuroprotect
effect
mous
nonhuman
primat
model
eae
suggest
possess
broader
plastic
function
vivo
inde
recent
demonstr
engraft
hescderiv
npc
hnpc
jhmvinfect
mice
establish
demyelin
result
clinic
histolog
improv
month
posttranspl
although
transplant
cell
reject
day
follow
inject
figur
contrast
mous
npc
hnpc
neither
migrat
extens
site
inject
appear
differenti
neural
lineag
hnpcmediat
recoveri
associ
increas
remyelin
given
hnpc
reject
within
rel
short
period
follow
inject
unlik
cell
directli
contribut
remyelin
believ
remyelin
result
acut
inflammatorymedi
reject
remyelin
axon
distribut
rostral
caudal
implant
site
rather
local
region
cell
deliveri
mice
transplant
hnpc
show
reduc
infiltr
effector
cell
spinal
cord
compar
transplant
control
total
number
regulatori
cell
treg
within
spinal
cord
elev
figur
deplet
treg
hnpctransplant
mice
via
treatment
inhibit
therapeut
benefit
highlight
potenti
import
cell
contribut
hnpcmediat
recoveri
figur
cultur
hnpc
secret
compar
undifferenti
hesc
counterpart
role
tgfin
impact
treg
mainten
homeostasi
well
establish
previou
work
shown
promot
express
peripher
treg
compart
influenc
frequenc
suppress
activ
therefor
one
potenti
mechan
result
enhanc
recoveri
mice
via
immunomodulatori
natur
hnpc
wherebi
express
antiinflammatori
cytokin
act
paracrin
manner
influenc
local
inflammatori
environ
within
spinal
cord
promot
accumul
treg
import
role
treg
acut
chronic
jhmv
infect
recent
demonstr
virusspecif
treg
dampen
prolifer
virusspecif
effector
cell
deplet
treg
increas
mortal
suggest
acut
jhmv
infect
treg
limit
immunopatholog
diseas
without
neg
impact
viral
clearanc
addit
studi
trandem
et
al
shown
adopt
transfer
treg
jhmvinfect
mice
attenu
clinic
diseas
sever
dampen
neuroinflamm
subsequ
demyelin
find
demonstr
therapeut
potenti
hnpc
promot
sustain
recoveri
promot
remyelin
limit
ongo
demyelin
mute
neuroinflamm
mice
infect
neurotroph
variant
mhv
result
persist
infect
lead
chronic
demyelin
promot
virusspecif
nonspecif
cell
macrophag
histopatholog
similar
mhvinfect
mice
chronic
neurolog
diseas
ms
make
attract
model
understand
function
npc
inflammatori
environ
review
highlight
recent
advanc
regard
use
mous
human
npc
amelior
sever
neuroinflamm
demyelin
within
context
viral
model
human
demyelin
ms
articl
also
provid
overview
potenti
npc
promot
remyelin
follow
transplant
transplant
mous
npc
physic
bind
remyelin
axon
result
increas
axon
integr
contrast
remyelin
observ
follow
hnpc
transplant
must
occur
resid
oligodendroglia
hnpc
rapidli
reject
level
detect
furthermor
studi
reveal
clear
differ
base
upon
cell
type
use
therapeut
intervent
transplant
mous
human
npc
led
remyelin
treatment
human
npc
result
dramat
reduct
neuroinflamm
accompani
overal
improv
clinic
diseas
compar
mous
npc
transplant
find
demonstr
immunomodulatori
natur
therapeut
potenti
hnpc
importantli
studi
deriv
viral
model
ms
illustr
surviv
transplant
cell
requir
restor
motor
skill
observ
indic
immunemedi
reject
allogen
npc
may
import
administr
immunosuppress
drug
may
necessari
promot
longterm
recoveri
futur
research
character
solubl
factor
releas
hnpc
impact
remyelin
affect
neuroinflamm
greatli
aid
defin
molecular
cellular
underpin
lead
recoveri
moreov
identif
factor
may
preclud
transplant
hnpc
may
possibl
deliv
molecul
promot
cn
repair
clinic
recoveri
futur
research
requir
confirm
extend
find
addit
research
continu
character
therapeut
potenti
npc
deriv
induc
pluripot
stem
cell
advantag
approach
includ
elimin
ethic
issu
confront
studi
util
esc
possibl
limit
alloreject
remain
import
hnpc
would
mhc
match
patient
elimin
need
lifelong
treatment
immunosuppress
drug
increas
eas
cultur
differenti
import
unmet
clinic
need
ms
patient
effect
method
induc
sustain
remyelin
limit
immun
cell
infiltr
cn
emphas
import
investig
therapeut
potenti
hnpc
yfp
axon
yellow
coloc
overlap
gfpnpc
green
mbp
fluoresc
determin
use
imari
coloc
tool
white
merg
three
channel
shown
right
scale
bar
npc
neural
precursor
cell
reproduc
permiss
reproduc
permiss
